Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients

The immunological pathogenesis of diffuse large B cell lymphoma (DLBCL) remains elusive. Searching for new prognostic markers of DLBCL is a crucial focal point for clinical scientists. The aim of the present study was to examine the prognostic value of interferon regulatory factor 8 (IRF8) expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Wei-Jie, Xu, Xin, Zhu, Zhi-Gang, Du, Qing-Hua, Du, Hong, Yang, Li, Ling, Yan-Ying, Xiong, Hua-Bao, Li, Qing-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564805/
https://www.ncbi.nlm.nih.gov/pubmed/28537908
http://dx.doi.org/10.18632/oncotarget.17693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564805/
https://www.ncbi.nlm.nih.gov/pubmed/28537908
http://dx.doi.org/10.18632/oncotarget.17693

Ejemplares similares